These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 28859262

  • 1. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
    Cossu M, van Bon L, Preti C, Rossato M, Beretta L, Radstake TRDJ.
    Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
    [Abstract] [Full Text] [Related]

  • 2. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, Distler O, Schett G, Distler JH, Ramming A.
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [Abstract] [Full Text] [Related]

  • 3. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
    Cossu M, Andracco R, Santaniello A, Marchini M, Severino A, Caronni M, Radstake T, Beretta L.
    Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
    [Abstract] [Full Text] [Related]

  • 5. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
    Yalçinkaya Y, Çinar S, Artim-Esen B, Kamali S, Öcal L, Deniz G, Inanç M.
    Clin Exp Rheumatol; 2016 Jun; 34 Suppl 100(5):110-114. PubMed ID: 27749243
    [Abstract] [Full Text] [Related]

  • 6. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R, Kazakova M, Sapundzhieva T, Dichev V, Batalov Z, Sarafian V, Batalov A.
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, Price PA, Jacobsen S.
    Scand J Rheumatol; 2005 Nov; 34(4):293-7. PubMed ID: 16195162
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [Abstract] [Full Text] [Related]

  • 13. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA.
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [Abstract] [Full Text] [Related]

  • 14. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hara T, Muroi E, Takehara K, Sato S.
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K.
    J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
    [Abstract] [Full Text] [Related]

  • 17. [Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia].
    Tiev KP, Chatenoud L, Kettaneh A, Tolédano C, Bach JF, Cabane J.
    Rev Med Interne; 2009 Nov; 30(11):942-6. PubMed ID: 19577826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.